• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠杆菌菌株与人类血清的相互作用:与K1抗原无关。

Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.

作者信息

Björkstén B, Bortolussi R, Gothefors L, Quie P G

出版信息

J Pediatr. 1976 Dec;89(6):892-7. doi: 10.1016/s0022-3476(76)80592-6.

DOI:10.1016/s0022-3476(76)80592-6
PMID:792409
Abstract

Twenty-eight strains of E. coli isolated from infants were compared with respect to opsonic requirements, sensitivity to serum, and ability to activate serum chemotactic factors. Six of the strains were isolated from stools of healthy newborn infants; 22 were isolated from the cerebrospinal fluid or blood of infants with meningitis and/or septicemia. Eighteen of the strains had K1 polysaccharide antigen. Fourteen of the strains (seven with K1 antigen) activated complement via the alternative pathway and all of these strains were well opsonized in 4% pooled human serum. A higher concentration of serum was necessary to opsonize 12 of the 14 strains that did not activate the alternative pathway. A wide variation was also found in opsonic requirements of E. coli strains isolated from healthy and sick infants. There was no relationship of the K1 antigen to opsonic requirements, to capacity to activate complement via the alternative pathway, to generation of chemotactic factors, or to sensitivity to serum cidal activity. Therefore, the association of E. coli with K1 antigen and neonatal meningitis did not appear to be related to these bacteria-serum interactions.

摘要

对从婴儿中分离出的28株大肠杆菌进行了比较,涉及调理素需求、对血清的敏感性以及激活血清趋化因子的能力。其中6株从健康新生儿粪便中分离得到;22株从患有脑膜炎和/或败血症婴儿的脑脊液或血液中分离得到。18株菌株具有K1多糖抗原。14株菌株(7株带有K1抗原)通过替代途径激活补体,并且所有这些菌株在4%混合人血清中均能被良好调理。对于另外14株未激活替代途径的菌株,需要更高浓度的血清才能将其中12株调理。从健康和患病婴儿中分离出的大肠杆菌菌株在调理素需求方面也存在很大差异。K1抗原与调理素需求、通过替代途径激活补体的能力、趋化因子的产生或对血清杀菌活性的敏感性均无关联。因此,大肠杆菌与K1抗原和新生儿脑膜炎的关联似乎与这些细菌 - 血清相互作用无关。

相似文献

1
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.大肠杆菌菌株与人类血清的相互作用:与K1抗原无关。
J Pediatr. 1976 Dec;89(6):892-7. doi: 10.1016/s0022-3476(76)80592-6.
2
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.大肠杆菌荚膜K1多糖:与新生大鼠毒力及抗吞噬作用的关系
Infect Immun. 1979 Jul;25(1):293-8. doi: 10.1128/iai.25.1.293-298.1979.
3
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.综述:大肠杆菌的侵袭性与K1荚膜多糖之间的关系
Pediatr Res. 1976 Feb;10(2):82-7. doi: 10.1203/00006450-197602000-00002.
4
Neonatal meningitis due of Escherichia coli K1.由大肠杆菌K1引起的新生儿脑膜炎。
J Infect Dis. 1977 Aug;136 Suppl:S93-7. doi: 10.1093/infdis/136.supplement.s93.
5
Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.ColV质粒和K1抗原对大肠杆菌致病性的相对贡献
Infect Immun. 1983 Apr;40(1):359-68. doi: 10.1128/iai.40.1.359-368.1983.
6
Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.大肠杆菌生长温度对K1荚膜抗原产生及抗调理吞噬作用的影响
Infect Immun. 1983 Mar;39(3):1136-41. doi: 10.1128/iai.39.3.1136-1141.1983.
7
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.人血清和中性粒细胞与大肠杆菌菌株的相互作用:从肾盂肾炎或无症状菌尿症患者尿液中分离出的菌株之间的差异。
Infect Immun. 1978 Nov;22(2):308-11. doi: 10.1128/iai.22.2.308-311.1978.
8
Epidemiology of Escherichia coli K1 in healthy and diseased newborns.健康及患病新生儿中大肠杆菌K1的流行病学研究
Lancet. 1975 May 17;1(7916):1099-104. doi: 10.1016/s0140-6736(75)92496-4.
9
Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.抗大肠杆菌K1、O及脂多糖A抗原抗体的相对调理及保护活性
Scand J Infect Dis. 1979;11(4):291-301. doi: 10.3109/inf.1979.11.issue-4.07.
10
Deficient alternative complement pathway activity in newborn sera.新生儿血清中替代补体途径活性不足。
Pediatr Res. 1979 Dec;13(12):1341-4. doi: 10.1203/00006450-197912000-00008.

引用本文的文献

1
Bile Salts Regulate Zinc Uptake and Capsule Synthesis in a Mastitis-Associated Extraintestinal Pathogenic Escherichia coli Strain.胆盐调节乳腺炎相关肠外致病性大肠杆菌菌株的锌摄取和荚膜合成。
Infect Immun. 2021 Sep 16;89(10):e0035721. doi: 10.1128/IAI.00357-21. Epub 2021 Jul 6.
2
Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.抗体依赖性增强细菌病:流行情况、机制与治疗。
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00054-21.
3
Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli.
荚膜和O抗原在尿路致病性大肠杆菌毒力中的作用。
PLoS One. 2014 Apr 10;9(4):e94786. doi: 10.1371/journal.pone.0094786. eCollection 2014.
4
Influence of serum concentration on opsonization by the classical and alternative complement pathways.血清浓度对经典和替代补体途径调理作用的影响。
Infect Immun. 1980 Feb;27(2):693-6. doi: 10.1128/iai.27.2.693-696.1980.
5
Serum opsonic activity in acute protein-energy malnutrition.急性蛋白质-能量营养不良时的血清调理活性
Bull World Health Organ. 1981;59(6):923-9.
6
Protection against Escherichia coli K1 infection in newborn rats by antibody to K1 capsular polysaccharide antigen.抗K1荚膜多糖抗原抗体对新生大鼠大肠杆菌K1感染的保护作用。
Infect Immun. 1980 Apr;28(1):111-7. doi: 10.1128/iai.28.1.111-117.1980.
7
Identification of Escherichia coli K1 antigen.大肠杆菌K1抗原的鉴定
J Clin Microbiol. 1984 Aug;20(2):302-4. doi: 10.1128/jcm.20.2.302-304.1984.
8
Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.大肠杆菌K1在体外和体内对氨苄西林与氯霉素反应之间的矛盾
Antimicrob Agents Chemother. 1984 Nov;26(5):689-93. doi: 10.1128/AAC.26.5.689.
9
Membrane changes induced by exposure of Escherichia coli to human serum.大肠杆菌暴露于人体血清所诱导的膜变化。
Infect Immun. 1983 Dec;42(3):1055-66. doi: 10.1128/iai.42.3.1055-1066.1983.
10
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.血清对革兰氏阴性菌的杀菌和溶菌活性。
Microbiol Rev. 1983 Mar;47(1):46-83. doi: 10.1128/mr.47.1.46-83.1983.